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Introduction {#jcsm12237-sec-0005}
============

Inadequate intake of micronutrients has been associated with a higher risk of frailty and impaired mobility in older adults.[1](#jcsm12237-bib-0001){ref-type="ref"}, [2](#jcsm12237-bib-0002){ref-type="ref"} While the most compelling evidence exists for a role of vitamin D deficiency (reviewed in Bischoff‐Ferrari[3](#jcsm12237-bib-0003){ref-type="ref"}), inadequate intake of other micronutrients has also directly or indirectly been associated with reduced physical activity and impaired muscle strength with advanced age.[4](#jcsm12237-bib-0004){ref-type="ref"}, [5](#jcsm12237-bib-0005){ref-type="ref"} Several of these micronutrients contribute to the antioxidant capacity, which is impaired during ageing.[6](#jcsm12237-bib-0006){ref-type="ref"} The increased production of reactive oxygen species with age that exceeds the antioxidant defence capacity[7](#jcsm12237-bib-0007){ref-type="ref"} may contribute to lower physical function and a reduced potential to adapt to muscle exercise and mechanical loading.[8](#jcsm12237-bib-0008){ref-type="ref"}, [9](#jcsm12237-bib-0009){ref-type="ref"}, [10](#jcsm12237-bib-0010){ref-type="ref"} An age‐related reduction in muscle mitochondrial DNA and an increased mtDNA oxidation could play a role in this phenomenon.[11](#jcsm12237-bib-0011){ref-type="ref"}, [12](#jcsm12237-bib-0012){ref-type="ref"} Moreover, an impaired muscle protein synthesis response to anabolic stimuli in ageing[13](#jcsm12237-bib-0013){ref-type="ref"} may be related to oxidative stress.[14](#jcsm12237-bib-0014){ref-type="ref"} For example, low serum levels of vitamins B6 and B12 predict an inability to perform the activities of daily living in community‐dwelling older women,[15](#jcsm12237-bib-0015){ref-type="ref"} and vitamin B12 deficiency has been suggested to contribute to the frailty syndrome.[16](#jcsm12237-bib-0016){ref-type="ref"} Inadequate intake of vitamins B6 and B12 may contribute to hyperhomocysteinemia, which is an indicator of oxidative stress.[17](#jcsm12237-bib-0017){ref-type="ref"} High serum homocysteine has been associated with reduced physical performance in older adults.[18](#jcsm12237-bib-0018){ref-type="ref"} Vitamin B12 deficiency is more severe in older adults due to food‐bound cobalamin malabsorption.[19](#jcsm12237-bib-0019){ref-type="ref"} An elevated plasma homocysteine level in 30--50% of adults over 60 years[20](#jcsm12237-bib-0020){ref-type="ref"} may also point towards suboptimal intake or metabolism of vitamins B6 and B12 and folate. The relevance of B vitamins is likely due to their action as cofactors in enzymatic reactions that are essential for cellular and mitochondrial functions.[21](#jcsm12237-bib-0021){ref-type="ref"} Hyperhomocysteinemia may, therefore, also be an indicator of oxidative stress.[22](#jcsm12237-bib-0022){ref-type="ref"} A deficiency of other micronutrients with antioxidant properties, such as carotenoids, selenium, and vitamin E, has also been negatively associated with sarcopenia (i.e. loss of muscle mass and function with age), frailty, and disability.[15](#jcsm12237-bib-0015){ref-type="ref"}, [23](#jcsm12237-bib-0023){ref-type="ref"}, [24](#jcsm12237-bib-0024){ref-type="ref"} A decreased blood value of selenium has been associated with low skeletal muscle mass and strength.[25](#jcsm12237-bib-0025){ref-type="ref"}, [26](#jcsm12237-bib-0026){ref-type="ref"}

While association studies suggest that deficiencies in micronutrients with antioxidant properties play a role in frailty and sarcopenia, a causal relationship is less well studied. We hypothesized that with this specific diet intervention, low in antioxidants, natural ageing is accelerated by a further decrease of muscle mass, strength, and physical function. Therefore, the aim of this study was to determine in aged mice the impact of a reduced dietary intake of vitamins A, E, B6, and B12, folate, selenium, and zinc on muscle mass, strength, and physical function over time. Vitamin C, a well‐described antioxidant, was not in scope of the diet intervention because mice can endogenously synthesize vitamin C.[27](#jcsm12237-bib-0027){ref-type="ref"} In addition, underlying determinants of these physical traits were explored, focusing on muscle force production, muscle mitochondrial density and muscle fibre characterization (i.e. number, size, and type), immune response, and muscle protein synthesis and breakdown. By creating a deficiency of these specific micronutrients in ageing mice, we were able to mimic the human situation and gain further insight into the relevance of such deficiencies for muscle health with age.

Methods {#jcsm12237-sec-0006}
=======

Animals {#jcsm12237-sec-0007}
-------

Male C57/BL6J mice of 21 months of age were obtained from Janvier Labs (Saint Berthevin, France). Animals were individually housed in a climate‐controlled room (12:12 dark--light cycle with a constant room temperature of 21 ± 1°C). Mice were *ad libitum* fed with a standard diet (AIN‐93‐M) and had free access to tap water. All diets were provided by Research Diets Services (Wijk bij Duurstede, the Netherlands). All experimental procedures were approved by the Animal Ethical Committee (DEC consult, Bilthoven, the Netherlands). After 2 weeks of acclimatization, mice were randomized in three different groups: (1) baseline control group at 21 months of age, (2) mice ageing until 25 months on a normal diet, and (3) mice ageing until 25 months on a diet low in antioxidants. The control group received AIN‐93‐M for 4 months (control diet, ageing control group, *n* = 11), and the other group (*n* = 11) received a diet lowered in vitamin A, E, B6, B12, folate, selenium, and zinc (=LOWOX‐B) to levels representing 50% of the daily recommended intake of lab rodents (*Table* [1](#jcsm12237-tbl-0001){ref-type="table-wrap"}).[28](#jcsm12237-bib-0028){ref-type="ref"} Because the non‐essential amino acid cysteine is a strong antioxidant,[30](#jcsm12237-bib-0030){ref-type="ref"} the LOWOX‐B diet was not fortified with cysteine as in AIN‐93‐M. Bodyweight and food intake were determined twice a week. For a schematic overview of the experimental setup, refer to *Figure* [1](#jcsm12237-fig-0001){ref-type="fig"}. During the total duration of the experiment, mice were carefully observed for symptoms of general malaise or signs of moribund conditions. After an overnight fast, mice were sacrificed by block randomization at 21 and 25 months of age; skeletal muscles from the hind limb (*tibialis anterior*, *extensor digitorum longus*, *soleus*, *plantaris*, and *gastrocnemius* muscle) and liver were dissected, weighted, and stored at −80°C until further use. The *plantaris* (PL) muscles were (control *n* = 8; LOWOX‐B *n* = 7) pinned on a piece of Sylguard (Dow Corning, the Netherlands) and frozen in liquid nitrogen as in van der Zwaard *et al*.[31](#jcsm12237-bib-0031){ref-type="ref"} Within a month after the excision, serial cross sections (10 μm) were cut from the mid‐belly of PL using a cryostat at −20°C. Sections were mounted on glass slides (Menzel‐Gläser, Superfrost^®^ plus, GER), air‐dried, and stored at −80°C until further use. The incubation of the sections for determination of succinate dehydrogenase activity (SDH) was performed[32](#jcsm12237-bib-0032){ref-type="ref"} immediately after sectioning and drying of the sections for 15 min at room temperature.

###### 

Composition of the intervention diets

  Diet name                                             Control diet      LOWOX‐B   RDA mouse[c](#jcsm12237-note-0004){ref-type="fn"}
  ----------------------------------------------------- ----------------- --------- ---------------------------------------------------
  Ingredients                                           g/kg dry matter             
  Cornstarch                                            466               466       Unknown
  Dextrinized cornstarch                                155               155       Unknown
  Casein                                                140               141.8     180
  [l]{.smallcaps}‐Cystine                               1.8               0         7.6[d](#jcsm12237-note-0005){ref-type="fn"}
  Sucrose                                               100               100       Unknown
  Soybean oil                                           40                40        50
  Fiber[a](#jcsm12237-note-0002){ref-type="fn"}         50                50        Unknown
  Mineral mix[b](#jcsm12237-note-0003){ref-type="fn"}   35                35        
  Selenium (mg/kg)                                      0.170             0.075     0.150
  Zinc (mg/kg)                                          35                5         10
  Vitamin mix[b](#jcsm12237-note-0003){ref-type="fn"}   10                10        
  Vitamin A (IU/kg)                                     4000              1200      2400
  Vitamin B6 (mg/kg)                                    6                 4         8
  Vitamin B12 (μg/kg)                                   25                5         10
  Folate (mg/kg)                                        2                 0.25      0.50
  Vitamin E (IU/kg)                                     75                16        32
  Choline bitrate chloride                              1.4               1.4       Unknown
  *tert‐*Butylhydroquinone                              0.008             0.008     Unknown

The LOWOX‐B diet was based on the control diet, except for the vitamin and mineral mixes. These mixes were prepared by leaving out vitamins A/E/B6/B12 and folate in the mixes and subsequently add these micronutrients in amounts as indicated in table. All diets were equal in amounts of protein (137.5 g), carbohydrates (674.6 g), fat (41.1 g), and kilocalorie (3718) per kilogram dry matter.

Fibre source is cellulose.

As basis for the nutritional preparation is the AIN‐93‐M mineral and vitamin mix[28](#jcsm12237-bib-0028){ref-type="ref"} used without addition of selenium, zinc, vitamins A, B6, B12, and E, and folate. Subsequently for the control mice, the amounts listed in the table were added and the lower amounts for the LOWOX‐B mice.

Known recommended minimal daily requirement for growing mice based on the intake of 5 g food per day per mouse.[29](#jcsm12237-bib-0029){ref-type="ref"}

7.6 g/kg is for cysteine plus phenylalanine,[29](#jcsm12237-bib-0029){ref-type="ref"} both included in the casein protein.

![Experimental set‐up. accl, acclimatization period; mo, months; LOWOX‐B, group of mice with diet low in specific micronutrients with antioxidant properties; DA, daily activity measurements; GS, *in vivo* muscle grip strength measurements; DEXA, body composition analyses; MPS, muscle protein synthesis analysis; MPB, muscle protein breakdown; O/N, overnight.](JCSM-9-146-g001){#jcsm12237-fig-0001}

Daily activity {#jcsm12237-sec-0008}
--------------

During the acclimatization period, daily activity was measured for 1 week as normalization. During the experiment, daily activity was measured at the start of the experiment and every subsequent month, each time for 1 week as described before.[33](#jcsm12237-bib-0033){ref-type="ref"}

Body composition {#jcsm12237-sec-0009}
----------------

Body composition, i.e. lean mass, fat mass, and bone mineral density/content, was measured by dual‐energy X‐ray absorptiometry scan under general anaesthesia (isoflurane) using a PIXImus imager (GE Lunar, Madison, WI, USA).

*In vivo* muscle strength {#jcsm12237-sec-0010}
-------------------------

*In vivo* muscle strength was measured as forelimb grip strength with a calibrated grip strength tester (Panlab, Cornella, Spain) by prompting the mouse to grip the trapeze bar with both forelimbs and pulling the mouse by the tail (proximal to the body) parallel to the orientation of the strain gauge and the trapeze bar.[34](#jcsm12237-bib-0034){ref-type="ref"} For mean grip strength analyses, a set included five repetitions, results were calculated as follows: (a) absolute mean grip strength and (b) absolute maximum grip strength, defined as the maximum tension recorded over five repetitions.

*Ex vivo* muscle function {#jcsm12237-sec-0011}
-------------------------

Contractile characteristics of the *extensor digitorum longus* (EDL) muscle were assessed *ex vivo*, as described previously.[33](#jcsm12237-bib-0033){ref-type="ref"}, [35](#jcsm12237-bib-0035){ref-type="ref"} Briefly, muscles were allowed to stabilize at their slack length in the organ bath (Hugo Sachs Elektronik, March‐Hugstetten, Germany), for 30 min in Kreb\'s Heinselet buffer (mM: NaCl 118, KCl 4.75, MgSO~4~ 1.18, CaCl~2~ 2.5, KH~2~PO~4~ 1.17, NaHCO~3~ 24.9, and glucose 10) at 30°C and continuously perfused with 95% O~2~ and 5% CO~2~, after which optimal stimulation current and tension were determined. Subsequently, force--frequency characteristics (10--167 Hz, 250 ms) were determined. Isometric force signals of the force--frequency curve were analysed for maximal and total force production.[33](#jcsm12237-bib-0033){ref-type="ref"} After 5 min of rest and refreshing of the buffer, muscles were subjected to a moderate exercise protocol. Muscles were stimulated (143 Hz, 250 ms) 100 times, and the force production and the fatigue index were calculated. The single maximal force production during the first 40 contractions of the exercise protocol was summed up, and the ratio between the mean of the first three contractions and of the last three contractions was used as fatigue index.[36](#jcsm12237-bib-0036){ref-type="ref"}, [37](#jcsm12237-bib-0037){ref-type="ref"}

*Ex vivo* muscle protein synthesis and breakdown {#jcsm12237-sec-0012}
------------------------------------------------

*Gastrocnemius* (GM) muscles were incubated *ex vivo* in Kreb\'s Heinselet buffer (refer to the previous section) with the addition of 0.1% BSA and 2 mM sodium pyruvate (=neutral buffer) (Sigma) at 36°C and continuously perfused with 95% O~2~ and 5% CO~2~. After 30 min of calibration, muscles were switched to either new neutral buffer or to neutral buffer with 100 μM leucine added (=anabolic buffer) and both containing 5 μM puromycin (Calbiochem). After additional 30 min, muscles were washed twice with PBS, and muscle protein synthesis was assessed by western blotting as described before.[38](#jcsm12237-bib-0038){ref-type="ref"}, [39](#jcsm12237-bib-0039){ref-type="ref"} Subsequently, for protein breakdown analysis, the neutral or anabolic buffer containing puromycin was collected and analysed for 3‐methylhistidine content by HPLC.[40](#jcsm12237-bib-0040){ref-type="ref"}

Gene expression analyses {#jcsm12237-sec-0013}
------------------------

Total RNA was extracted using Trizol in combination with Ambion RNAquous micro kit (Fischer Scientific, Amsterdam, the Netherlands) from approximately 500 ng of EDL muscle samples. The quantity and purity of RNA were determined by NanoDrop^®^ spectrophotometer (Isogen Life Science, Belgium). cDNA was synthesized from 1 mg of RNA using the Superscript Vilo cDNA synthesis kit (Fischer Scientific, Amsterdam, the Netherlands) according to the manufacturer\'s instructions. Real‐time quantitative PCR reactions were performed using a StepOne real‐time PCR system (Applied Biosystems). Mouse‐specific primers for atrogin/ MAFbx and MuRF1 were designed (*Table* [2](#jcsm12237-tbl-0002){ref-type="table-wrap"}). Samples were analysed in duplicate, and the values normalized to 18S rRNA. Melting curves were systematically analysed to ensure the specificity of the amplification process. Relative quantities were calculated with the standard curve method.

###### 

Primer sequence (5′‐3′)

  Target gene              Forward                 Reverse
  ------------------------ ----------------------- ----------------------
  Atrogin/MuRF1 (Trim63)   TGCCCCCTTACAAAGCATCTT   CAGCATGGAGATGCAATTGC
  Mafbx (Fbxo32)           TGAAGACCGGCTACTGTGGAA   CGGATCTGCCGCTCTGA
  18S rRNA                 GTAACCCGTTGAACCCCATT    GTAACCCGTTGAACCCCATT

Biochemical nutrient status measurements {#jcsm12237-sec-0014}
----------------------------------------

Blood samples were taken via cardiac puncture and collected in tubes coated with heparin. Plasma was obtained by centrifugation at 1300*g* for 10 min at 4°C and stored at −80°C. Plasma and freeze‐dried liver samples for analyses of vitamins E and A were mixed with ethanol and centrifuged. The content of retinol and α‐tocopherol was determined in supernatant by HPLC, using UV absorbance for detection of retinol and fluorometric properties for detection of α‐tocopherol, by comparing with standard solutions. Serum samples were used for immunological parameters: Bio‐Plex Pro Mouse kits (Th17 panel A 6‐plex, IL‐15, MIP‐2) were used according to the manufacturer\'s description (Bio‐Rad). Small *n* is due to limitation of serum samples.

Liver malondialdehyde {#jcsm12237-sec-0015}
---------------------

After cryo‐desiccation of total liver, 10 mg of the liver was used to perform malondialdehyde (MDA) analysis, a marker for lipid peroxidation.[41](#jcsm12237-bib-0041){ref-type="ref"} In short, thiobarbituric reacts with MDA at pH 3.5. Thiobarbituric--MDA adduct is separated in a reversed‐phase column and quantified by fluorescence detection (ex 515 nm; em 553 nm).

Liver glutathione {#jcsm12237-sec-0016}
-----------------

To determine total glutathione (tGSH) content as a marker for whole‐body oxidative stress, another 10 mg of liver was used. For tGSH analyses, 0.4 M perchloric acid was added. The samples were placed in an ultrasonic bath for 30 min, vortexed, and centrifuged for 10 min at 13 000 rpm. The supernatant was diluted 100 times in phosphate‐EDTA buffer (0.1 M, pH 7.5). Subsequently, 40 μL sample and 20 μL DTNB (2.38 g/L in phosphate‐EDTA buffer) reagent, 40 μL glutathione reductase (10 μL/mL in phosphate‐EDTA buffer), and 100 μL NADPH (0.333 g/L in phosphate‐EDTA buffer) were added, and the plate was read immediately. Measurements were performed every 21 s at 405 nm during 4 min. Maximal velocity was calculated over at least seven measurements. Sample concentrations were calculated as micromole per milligram dry tissue.

Muscle fibre typing {#jcsm12237-sec-0017}
-------------------

For myosin heavy chain typing, serial sections were immunohistochemically stained against types I, IIA, IIX, and IIB myosin heavy chains as described before[31](#jcsm12237-bib-0031){ref-type="ref"} using monoclonal antibodies BAD5 (1 μg/mL), SC‐71 (1 μg/mL), 6H1 (10 μg/mL), and BF‐F3 (1--10 μg/mL) (Developmental Studies Hybridoma Bank, USA), respectively. Briefly, sections were fixated with acetone for 10 min at 4°C and washed in phosphate‐buffered saline with 0.05% Tween‐20 (PBST, Sigma‐Aldrich, the Netherlands) three times for 5 min at room temperature. After blocking with 10% normal swine serum for 30 min, sections were co‐incubated for 90 min with primary antibodies against type I and type IIB or against type IIA and type IIX. Subsequently, sections were washed in PBST three times for 3 min and incubated for 30 min in the dark with secondary antibodies against mouse IgG2b (Alexa Fluor 488, 1:200), IgG1 (Alexa Fluor 488, 1:200), and IgM (Alexa Fluor 647, 1:200) (Invitrogen, USA, Life Technologies, the Netherlands); sections were incubated with wheat germ agglutinin (1:50, Life Technologies, the Netherlands) for 20 min, washed in PBST, and subsequently washed once more in PBS, all in the dark. Then, sections were enclosed with Vectashield^®^ hardset mounting medium with DAPI (1.5 μg/mL; Vector Laboratories, USA). Images were captured using a CCD camera (PCO; Sensicam, Kelheim, Germany) at 20× objective connected to a fluorescent microscope (Axiovert 200M; Zeiss, Göttingen, Germany) across the entire cross section using image processing software (Slidebook 4.1; Intelligent Image Innovations, Denver, CO) and were assembled into a composite image.

Analyses of succinate dehydrogenase activity {#jcsm12237-sec-0018}
--------------------------------------------

Succinate dehydrogenase activity, an indicator of mitochondrial oxidative capacity (VO~2~max),[42](#jcsm12237-bib-0042){ref-type="ref"} was determined according to the protocol described by Pool *et al*.[32](#jcsm12237-bib-0032){ref-type="ref"} Sections were incubated for SDH activity in a medium consisting of 37.5 mM sodium phosphate buffer, pH 7.6, 75 mM sodium succinate, 5 mM sodium azide, and 0.4 mM tetranitro blue tetrazolium, in the dark at 37°C for 20 min. The reaction was stopped in 10 mM HCl. The staining intensity of SDH was determined by measuring the absorbance of the final reaction product using a Leica DMRB microscope (Wetzlar, Germany) and an interference filter at 660 nm (*A* ~660~). This absorbance was converted to the rate of staining and expressed as absorbance units (*A* ~660~) per micrometre section thickness per second of incubation time (Δ*A* ~660~·μm^−1^ section thickness s^−1^ incubation time), where Δ*A* ~660~ is the change in absorbance at 660 nm. To assess the oxidative capacity of the muscle fibres, SDH activity was multiplied by the muscle fibre cross‐sectional area (refer in the succeeding texts) which yielded the spatially integrated SDH activity (Δ*A* ~660~·μm section thickness s^−1^ incubation time). The spatially integrated SDH activity is proportional to the VO2max per millimetre of fibre length (in nmol μm^−1^ [s]{.smallcaps} ^−1^) of the cell.[42](#jcsm12237-bib-0042){ref-type="ref"}

Assessment of muscle fibre cross‐sectional area {#jcsm12237-sec-0019}
-----------------------------------------------

The cross‐sectional area of muscle fibres and absorbance values of the final SDH reaction product in muscle fibre sections were determined as follows. Sections were imaged using a Leica DMRB microscope (Wetzlar, Germany) fitted with calibrated grey filters using an appropriate interference filter (refer to the previous texts). Images were recorded with a 20× objective and a Sony XC‐77CE camera (Towada, Japan) connected to an LG‐3 frame grabber (Scion, USA) in an Apple Power Macintosh computer and analysed with NIH Image V1.61 (US National Institutes of Health). Grey values were converted to absorbance values per pixel using the grey filters and a third‐degree polynomial fit. Morphometry was calibrated using a slide micrometre and the set scale option in NIH Image, taking the pixel‐to‐aspect ratio into account. For each muscle cross section, images were taken from the high and low oxidative region, and for each fibre type, at least 20 muscle fibres were selected and measured. The public domain software ImageJ 1.45s (Rasband, W.S., ImageJ US National Institutes of Health, Bethesda, MD, USA) was used to measure the cross‐sectional area (CSA) and absorbances.

Statistical analyses {#jcsm12237-sec-0020}
--------------------

All data are expressed as means ± standard error of the mean (SEM). Statistical analyses were performed using SPSS 19.0 (SPSS Benelux, Gorinchem, the Netherlands). For randomization of experimental groups based on body weight and all other experimental outcomes, statistical analyses were performed by the use of a mixed model ANOVA with *post hoc* SIDAK testing, including mouse numbers, diet, and age as covariates. Bodyweight results were analysed by GLM analyses with *post hoc* SIDAK testing. *Ex vivo* skeletal muscle function data were analysed by mixed model ANOVA corrected for growth curve analyses with *post hoc* LSD. Muscle immunohistochemical analyses were tested with ANOVA and *post hoc* Bonferronni corrections. Differences were considered significant at a *P* value below 0.05.

Results {#jcsm12237-sec-0021}
=======

Mortality {#jcsm12237-sec-0022}
---------

Mortality at the start of the experiment, i.e. after 2 weeks of acclimatization, was none. Mortality over 16 weeks was 45.6% (5 of 11 mice) in the control group and 9.1% (1 of 11 mice) in the LOWOX‐B group. Cause of death in the control group was as follows: Two mice were taken out of the experiment due to preliminary death; during autopsy, no visible abnormalities were found, pointing towards ageing as being the cause of death. Another two mice were excluded due to liver tumours discovered during sections. One mouse was excluded due to a general decrease in well‐being and decrease in body weight with an enlarged heart and spleen observed at autopsy. The mouse in the LOWOX‐B group was taken out of the experiment due to preliminary death; autopsy revealed no visible cause.

Biomarkers of nutritional and oxidative status {#jcsm12237-sec-0023}
----------------------------------------------

As shown in *Figures* [2](#jcsm12237-fig-0002){ref-type="fig"}A and [2](#jcsm12237-fig-0002){ref-type="fig"}C, plasma levels of vitamin A and homocysteine (a biomarker for vitamins B6 and B12 and folate status) showed a significant age effect (*P* \< 0.013), but no significant diet effect. In contrast, plasma levels of vitamin E were significantly (65%) lowered by the LOWOX‐B diet already after 1 month (data not shown) and continued to be significantly lower throughout the total duration of the experiment (*P* \< 0.0001, *Figure* [2](#jcsm12237-fig-0002){ref-type="fig"}B). The presence of elevated oxidative stress levels was assessed by analyses of liver GSH and MDA. *Figures* [2](#jcsm12237-fig-0002){ref-type="fig"}D and [2](#jcsm12237-fig-0002){ref-type="fig"}E show that there was no significant age effect from 21 to 25 months of age \[only a tendency for an age‐related decline in GSH (*P* = 0.055)\]; however, MDA levels were significantly increased after 4 months of LOWOX‐B diet compared with those in control mice (*P* = 0.018).

![Biomarkers of nutritional and oxidative status at start (*t* = 0) and after 4 months of LOWOX‐B diet. (A) Vitamin A plasma levels, (B) homocysteine plasma levels, (C) vitamin E plasma levels, (D) hepatic total GSH levels, and (E) hepatic MDA levels. At start *n* = 11, ctrl *n* = 6, and LOWOX‐B *n* = 10. Different characters indicate statistically significant differences (mixed model with *post hoc* SIDAK, *P* \< 0.05).](JCSM-9-146-g002){#jcsm12237-fig-0002}

Bodyweight, food intake, and body composition {#jcsm12237-sec-0024}
---------------------------------------------

As shown in *Figure* [3](#jcsm12237-fig-0003){ref-type="fig"}A, bodyweight of the LOWOX‐B mice significantly deviated from control mice from 2 months after start of the diet (*P* \< 0.0001). Food intake did not significantly differ between the diet groups (ctrl: 0.105 ± 0.003 g/g BW/day, LOWOX‐B: 0.110 ± 0.003 g/g BW/day). Lean mass (*Figure* [3](#jcsm12237-fig-0003){ref-type="fig"}B) and fat mass (*Figure* [3](#jcsm12237-fig-0003){ref-type="fig"}C) were already significantly decreased in the LOWOX‐B mice after 1 month compared with control mice (resp., *P* = 0.036 and *P* \< 0.0001). In contrast to the LOWOX‐B mice, control mice significantly increased their fat mass from 21 to 25 months of age (*P* \< 0.002). This was confirmed by the weight of absolute fat storages as shown in *Table* [2](#jcsm12237-tbl-0002){ref-type="table-wrap"}. The sum of hind limb muscles as well as individual muscle weights (*Table* [3](#jcsm12237-tbl-0003){ref-type="table-wrap"}) was not affected by the LOWOX‐B diet.

![Effects of age and LOWOX‐B diet on body composition and physical strength. (A) Bodyweight development, (B) lean mass, (C) fat mass, (D) absolute maximal forelimb strength, with a trend (*P* = 0.073) to decreased strength after 4 months of the LOWOX‐B diet, and (E) mean total daily physical activity. At start *n* = 11, ctrl *n* = 6 and LOWOX‐B *n* = 10. \*Statistically significant age effect, \#statistically significant diet effect at indicated time point (mixed model with *post hoc* SIDAK, *P* \< 0.05).](JCSM-9-146-g003){#jcsm12237-fig-0003}

###### 

Individual muscle weights (mg) and absolute fat mass at different storages (mg)

                        Baseline         Control                                                 LOWOX‐B
  --------------------- ---------------- ------------------------------------------------------- -----------------------------------------------------------
  Age (months)          21               25                                                      25
  *n*                   11               6                                                       10
  Tibialis anterior     53.13 ± 0.98     56.28 ± 1.62[\*](#jcsm12237-note-1004){ref-type="fn"}   58.23 ± 1.83[\*](#jcsm12237-note-1004){ref-type="fn"}
  EDL                   10.97 ± 0.37     12.96 ± 0.41[\*](#jcsm12237-note-1004){ref-type="fn"}   12.76 ± 0.54[\*](#jcsm12237-note-1004){ref-type="fn"}
  Soleus                11.52 ± 0.28     10.83 ± 0.42                                            10.08 ± 0.22
  Plantaris             15.95 ± 0.40     19.75 ± 0.60[\*](#jcsm12237-note-1004){ref-type="fn"}   19.93 ± 0.52[\*](#jcsm12237-note-1004){ref-type="fn"}
  SUM                   91.57 ± 1.57     99.82 ± 2.83[\*](#jcsm12237-note-1004){ref-type="fn"}   100.99 ± 2.55[\*](#jcsm12237-note-1004){ref-type="fn"}
  Epididymis fat        n/m              1125.82 ± 236.34                                        516.51 ± 78.21[\*\*](#jcsm12237-note-1005){ref-type="fn"}
  Dorsal fat            n/m              52.78 ± 7.62                                            31.89 ± 3.40[\*\*](#jcsm12237-note-1005){ref-type="fn"}
  Brown fat             n/m              225.43 ± 43.95                                          122.69 ± 10.12[\*\*](#jcsm12237-note-1005){ref-type="fn"}
  Liver                 1144.72 ± 0.03   1355.28 ± 0.16                                          1133.80 ± 0.03
  Heart                 149.56 ± 4.13    192.18 ± 13.36                                          176.54 ± 6.27[\*\*](#jcsm12237-note-1005){ref-type="fn"}
  Myeloid lymph nodes   42.47 ± 6.57     49.22 ± 10.74                                           27.73 ± 4.82

n/m, not measured.

Statistically significant age effect on muscle mass (no diet effect) from 21 to 25 months of age.

Statistically significant diet effect at 25 months of age (mixed model analysis with *post hoc* SIDAK, *P* \< 0.05).

Muscle strength and physical activity {#jcsm12237-sec-0025}
-------------------------------------

Maximal grip strength declined with age (*P* = 0.04). During 4 months on the LOWOX‐B diet, mice showed significantly lower maximal grip strength compared with control mice (*P* = 0.013) (*Figure* [3](#jcsm12237-fig-0003){ref-type="fig"}D). Total daily activity was significantly decreased with ageing, and LOWOX‐B mice showed an even further decrease compared with control mice during ageing (*P* \< 0.001) (*Figure* [3](#jcsm12237-fig-0003){ref-type="fig"}E). The decrease in total daily activity was due to less activity of the LOWOX‐B mice during the dark (active) period; there were no significant changes in activity levels during the light (inactive) period (control: 114.42 ± 36.18 counts; LOWOX‐B: 102.89 ± 32.54 counts).

*Ex vivo* muscle function {#jcsm12237-sec-0026}
-------------------------

Force--frequency relationship analysis showed that maximal force production (*Figure* [4](#jcsm12237-fig-0004){ref-type="fig"}A) was not significantly affected by the LOWOX‐B diet for the total curve (*P* = 0.089). However, significant differences were found between the diet groups in the lower frequency range at 67 and 83 Hz (resp., *P* = 0.015 and *P* = 0.038). The LOWOX‐B mice showed a significantly lower contraction velocity over the full frequency range (*P* = 0.048, *Figure* [4](#jcsm12237-fig-0004){ref-type="fig"}B) with no effect on relaxation velocity (*P* = 0.208, *Figure* [4](#jcsm12237-fig-0004){ref-type="fig"}C). However, a significantly lower relaxation velocity value in the LOWOX‐B group was observed at individual frequencies of 40, 67, and 167 Hz (resp., *P* = 0.030, *P* = 0.025, and *P* = 0.05, *Figure* [4](#jcsm12237-fig-0004){ref-type="fig"}C).

![*Ex vivo* muscle function: effects of 4 month LOWOX‐B diet on force--frequency of EDL muscle. (A) Maximal force production, (B) contraction velocity, and (C) relaxation velocity. Ctrl *n* = 6 and LOWOX‐B *n* = 10. \@Overall statistically significant diet effect, \#statistically significant diet effect at indicated time point (mixed model adjusted for growth curve analysis with *post hoc* SIDAK, *P* \< 0.05) and ns not significant.](JCSM-9-146-g004){#jcsm12237-fig-0004}

After a moderate exercise protocol, force development and endurance were compromised in LOWOX‐B mice compared with control mice (*P* = 0.01) (*Figure* [5](#jcsm12237-fig-0005){ref-type="fig"}A). Moreover, LOWOX‐B mice showed a significantly lower maximal force production during the first 25 contractions of the exercise protocol (*P* = 0.010, *Figure* [5](#jcsm12237-fig-0005){ref-type="fig"}B) and lower contraction velocity (*P* = 0.028, *Figure* [5](#jcsm12237-fig-0005){ref-type="fig"}C). Relaxation velocity was not affected by the diet (*P* = 0.278, *Figure* [5](#jcsm12237-fig-0005){ref-type="fig"}D). LOWOX‐B mice were less resistant to fatigue after the exercise protocol, as indicated by the lower fatigue index (*P* = 0.023) (*Figure* [5](#jcsm12237-fig-0005){ref-type="fig"}E).

![*Ex vivo* muscle function: effects of 4 month LOWOX‐B diet on exercise performance. (A) Maximal rate of force production, (B) maximal force production during first 25 contractions of exercise protocol, (C) contraction velocity development, (D) relaxation velocity development, and (E) fatigue index. Ctrl *n* = 6 and LOWOX‐B *n* = 10. Different characters indicate a statistically significant diet effect (mixed model with *post hoc* SIDAK, *P* \< 0.05).](JCSM-9-146-g005){#jcsm12237-fig-0005}

*Ex vivo* muscle protein synthesis and breakdown {#jcsm12237-sec-0027}
------------------------------------------------

As shown in *Figure* [6](#jcsm12237-fig-0006){ref-type="fig"}A, GM muscle of LOWOX‐B mice did not show an increase in muscle protein synthesis after incubation with leucine when compared with neutral buffer (basal state). This was in contrast to control mice (fasted compared with leucine stimulated, *P* = 0.039; leucine‐stimulated control vs. LOWOX‐B mice, *P* = 0.036). Muscle protein breakdown was significantly increased in LOWOX‐B mice compared with control (*Figure* [6](#jcsm12237-fig-0006){ref-type="fig"}B). In addition to the *ex vivo* 3‐methylhistidine measurements, MAFbx/atrogin gene expression of the EDL muscle was significantly increased (*P* = 0.01), and MuRF1 showed a similar trend (*Figures* [6](#jcsm12237-fig-0006){ref-type="fig"}C and 6D).

![*Ex vivo* muscle protein synthesis (MPS) and breakdown (MPB). (A) MPS in GM muscles and (B) MPB in buffer of GM muscle, (C) atrogin/MAFbx EDL gene expression and (D) MuRF1 EDL gene expression at 25 months of age after 4 month diet. Ctrl *n* = 6 and LOWOX‐B *n* = 10. MPS was measured during incubation with neutral buffer (basal state) and after addition of leucine (anabolic buffer). Different characters indicate a statistically significant difference (mixed model with *post hoc* SIDAK, *P* \< 0.05).](JCSM-9-146-g006){#jcsm12237-fig-0006}

Plantaris fibre typing, muscle fibre cross‐sectional area, and succinate dehydrogenase activity {#jcsm12237-sec-0028}
-----------------------------------------------------------------------------------------------

Within the PL muscle, a distinction was made between a more oxidative part and a more glycolytic part (*Figures* [7](#jcsm12237-fig-0007){ref-type="fig"}C and [7](#jcsm12237-fig-0007){ref-type="fig"}F). Close to the proximal aponeurosis, there were more oxidative fibres. Type IIA was hardly found in the glycolytic part of the muscle (*Figures* [7](#jcsm12237-fig-0007){ref-type="fig"}A and 7D). Besides that, muscle fibre type I was barely present in the PL muscle (*Figures* [7](#jcsm12237-fig-0007){ref-type="fig"}B and [7](#jcsm12237-fig-0007){ref-type="fig"}E). Therefore, type I muscle fibres were not included in fibre CSA (fCSA) and SDH activity analysis.

![Effects of 4 month LOWOX‐B diet on PL muscle fibre‐type distribution, fibre CSA, and SDH activity. (A--F) Typical examples of PL muscle cross sections with double immunofluorescent labelled muscle fibres for either myosin heavy chain types IIA and IIX (A and D; green type IIA and blue type IIX) or types I and IIB (B and E, green type I and blue type IIB) or stained for SDH activity (C and F). The basal lamina, intramuscular connective tissue, and aponeuroses were stained red by wheat germ agglutinin. Note that around the distal, aponeurosis is the high oxidative region with predominantly type IIA, IIAX, IIX, and IIB muscle fibres. On the outer side, is the low oxidative (glycolytic) region with predominantly type IIX and IIB muscle fibres. (G) Muscle fibre‐type distributions. (H) Mean CSA for the different muscle fibre types. (I) SDH activity in the different muscle fibres types. (J) Spatially integrated SDH activity (i.e. product of muscle fibre CSA and SDH activity). Ctrl: *n* = 8 and LOWOX‐B: *n* = 7. Scale bar indicates 300 μm. \*Statistically significant difference (*P* \< 0.05).](JCSM-9-146-g007){#jcsm12237-fig-0007}

For both glycolytic and oxidative regions, mean fCSA and SDH activity of each muscle fibre type is presented in *Figures* [7](#jcsm12237-fig-0007){ref-type="fig"}G--7J. Muscle fibre type showed a significant interaction effect of diet and region (*P* \< 0.003) (*Figure* [7](#jcsm12237-fig-0007){ref-type="fig"}G). *Post hoc* analysis showed that types IIX and IIB muscle fibres of the glycolytic region of LOWOX‐B mice were significantly smaller than those of control mice (*P* \< 0.01), whereas fCSA in the oxidative region did not differ between the two diets (*Figure* [7](#jcsm12237-fig-0007){ref-type="fig"}H). SDH activity in both oxidative and glycolytic region of the PL muscle differed per fibre type (*P* \< 0.001), but was not affected by diet nor region. As *Figure* [7](#jcsm12237-fig-0007){ref-type="fig"}J shows, the spatially integrated SDH activity differed significantly for muscle fibre type (*P* \< 0.001) as well as for diet (*P* \< 0.028) between LOWOX‐B and control mice. *Post hoc* analysis showed that integrated SDH activity in the glycolytic region was significantly lower in the LOWOX‐B diet group than in the control group.

Immunological parameters {#jcsm12237-sec-0029}
------------------------

As shown in *Table* [4](#jcsm12237-tbl-0004){ref-type="table-wrap"}, the immune serum parameters measured did not show any significant difference between control and LOWOX‐B mice. Serum levels of IL‐10 and IL‐1b were below detection levels.

###### 

Serum immune parameters (pg/mL)

                 Control        LOWOX‐B
  -------------- -------------- -------------
  Age (months)   25             25
  *n*            6              9
  TNFα           135.8 ± 34.6   98.5 ± 15.5
  IFNγ           0.632 ± 0.1    0.922 ± 0.2
  IL‐6           7.6 ± 2.0      7.2 ± 1.3
  IL‐17a         5.7 ± 0.8      5.0 ± 0.6
  IL‐15          968.6 ± 41.3   1152 ± 100
  MIP‐2          19.21 ± 5.7    18.29 ± 1.0
  IL‐1b          n.d.           n.d.
  IL‐10          n.d.           n.d.

n.d., not detectable.

Discussion {#jcsm12237-sec-0030}
==========

The current study shows that reduced dietary intake of a combination of vitamins A, E, B6, and B12, folate, selenium, and zinc in aged mice resulted in a lower oxidative capacity and has a major impact on muscle health, by reducing muscle function and physical activity of the mice. The effect on m. EDL function was particularly evident after moderate exercise with decreased maximal force production and increased muscle fatigue. The decreased CSA of the glycolytic fibres of the m. plantaris, in combination with unaltered SDH activity per fibre between the groups, suggests muscle fibre atrophy (i.e. smaller fibres) and reduced muscle mitochondrial capacity, without an effect on total muscle mass. In addition, the rate of muscle protein synthesis in response to leucine was impaired in muscles of the LOWOX‐B mice, while the rate of muscle protein breakdown was increased.

Deficiencies of micronutrients with antioxidant properties (e.g. vitamins A and E, selenium and zinc, B vitamins B6, and B12, and folate) have been associated with frailty and sarcopenia in humans.[17](#jcsm12237-bib-0017){ref-type="ref"}, [43](#jcsm12237-bib-0043){ref-type="ref"}, [44](#jcsm12237-bib-0044){ref-type="ref"}, [45](#jcsm12237-bib-0045){ref-type="ref"} Our study shows that a decrease of these specific micronutrients in the diet of aged mice causes a decrease of serum vitamin E and an increase in liver MDA. These effects indicate increased oxidative stress in the mice kept on the LOWOX‐B diet. The absence of a decrease in plasma vitamin A levels in the LOWOX‐B group is not surprising, because previous studies in mice showed that serum vitamin A concentrations remain normal, even after 20 weeks of vitamin A deprivation.[46](#jcsm12237-bib-0046){ref-type="ref"}, [47](#jcsm12237-bib-0047){ref-type="ref"} Moreover, we observed no effect on plasma homocystein levels after reduced nutritional intake of vitamins B6/B12/folate, indicating that mice were not deficient. However, an age‐related increase in plasma homocystein was observed, which indicates that vitamin B metabolism is already affected by ageing *per se*.[6](#jcsm12237-bib-0006){ref-type="ref"}, [20](#jcsm12237-bib-0020){ref-type="ref"}, [48](#jcsm12237-bib-0048){ref-type="ref"} Similarly, GSH levels decreased with advanced age, indicative of increased systemic oxidative stress with ageing. The absence of a further decrease in the LOWOX‐B group could be due to a compensatory mechanism. These data show that in these aged mice, oxidative stress was further enhanced due to the micronutrient‐deficient diet.

Our study showed further that physical activity and muscle function were substantially compromised. Grip strength decreased gradually with age and was lowest in the LOWOX‐B group. Because for both groups the mass of all muscles of the lower leg was slightly increased compared with the values of the baseline group at 21 months of age, this indicates that the decrease in force generating capacity from the age of 21 months was mainly due to a reduction in specific force and/or a reduction in the number of muscle fibres. The initial reduction in muscle quality in ageing mice has been reported before.[49](#jcsm12237-bib-0049){ref-type="ref"} Maximal *ex vivo* EDL tetanic force of the LOWOX‐B group was substantially lower compared with that of the control group (\~50%). In addition, we observed atrophy in fast glycolytic fibres from LOWOX‐B *PL* muscle (\~20% compared with control). Due to lack of additional tissue, we have not been able to determine the percentage of atrophy in the EDL muscle. However, we did observe increased atrogin/MAFbx gene expression, suggesting that proteolysis was increased. Combined observations in these two different muscles, we hypothesize that the loss in force generating capacity due to low antioxidants caused both a further reduction in specific force and muscle fibre atrophy.

Moreover, the compromised muscle function was particularly apparent during a moderate exercise protocol, showing lowered maximal force production, lowered contraction velocity, and decreased resistance to fatigue. There have been only a few animal studies reporting the impact of deficiencies of individual or combined micronutrients with antioxidant properties on muscle health.[46](#jcsm12237-bib-0046){ref-type="ref"}, [47](#jcsm12237-bib-0047){ref-type="ref"}, [50](#jcsm12237-bib-0050){ref-type="ref"}, [51](#jcsm12237-bib-0051){ref-type="ref"} This study tested the effect of a combination of deficiencies. Vitamin E and/ or selenium deficiency has been associated with muscle dystrophy or white muscle disease in ruminant livestock,[52](#jcsm12237-bib-0052){ref-type="ref"} with symptoms that include muscle weakness and impaired gait. Vitamin E‐deficient young mice showed ataxia and neuromuscular deficits,[51](#jcsm12237-bib-0051){ref-type="ref"} which could have a negative impact on muscle function. Labazi *et al*.[53](#jcsm12237-bib-0053){ref-type="ref"} showed that rats deficient of vitamin E displayed increased fatigue and a disabled membrane repair function after being challenged with eccentric contraction‐induced membrane disruptions. The authors, therefore, suggested that vitamin E plays an important role in muscle force generating capacity as a requisite component for plasma membrane repair mechanisms. Our results in the LOWOX‐B group are in line with these findings. Our observation that fatigue resistance was affected as well suggests that mitochondrial membrane may also be compromised by the reduced vitamin E. Note that lowering of daily physical activity and grip strength was already observed in our control mice at advanced age. This indicates that ageing *per se* has an impact on physical activity and is worsened by increased oxidative stress.

While muscle function was clearly compromised by the LOWOX‐B diet, muscle mass was not affected in the LOWOX‐B group. However, we observed a decrease in CSA of glycolytic fibres with similar SDH activity levels, suggesting that LOWOX‐B mice had smaller and less and/or shorter muscle fibres. The combination of effects on muscle fibre size and oxidative capacity is reflected in the spatially integrated SDH activity, which is representative for the oxidative capacity determining the maximal steady‐state power of a muscle *in vivo*. The reduction in integrated SDH activity could mean that either the mitochondrial volume density was lower,[54](#jcsm12237-bib-0054){ref-type="ref"} mitochondrial function was compromised[55](#jcsm12237-bib-0055){ref-type="ref"}, or both. Of course, mitochondrial functioning depends not only on its density but also on its dynamics.[56](#jcsm12237-bib-0056){ref-type="ref"} Mitochondrial fusion and fission processes were not investigated in this recent study. Nutritional vitamin B6/B12/folate deficiency is likely relevant in this context due to their action as cofactors in enzymatic reactions that are essential for cellular and mitochondrial functions.[21](#jcsm12237-bib-0021){ref-type="ref"}

The impaired *ex vivo* muscle protein synthesis response of GM muscle to leucine on the LOWOX‐B diet and increased muscle protein breakdown as confirmed by increased atrogin/MAFbx gene expression in the *EDL* muscle point towards a change in muscle (protein) metabolism and reduced anabolic sensitivity. Our findings on impaired muscle protein synthesis after an anabolic stimulus with leucine fit those of the study by Dardevet *et al*.[14](#jcsm12237-bib-0014){ref-type="ref"}, [57](#jcsm12237-bib-0057){ref-type="ref"} who showed that antioxidant supplementation in combination with leucine has a synergistic effect on muscle protein anabolism in aged rats. Another hypothesis that warrants further research is that endoplasmic reticulum stress may contribute to the impaired anabolic response in these deficient mice.[58](#jcsm12237-bib-0058){ref-type="ref"}, [59](#jcsm12237-bib-0059){ref-type="ref"} In addition, the unfolded protein response may result in non‐functional protein and also impair muscle quality with respect to the force‐generating capacity as well as fatigue resistance.[58](#jcsm12237-bib-0058){ref-type="ref"} Surprisingly, LOWOX‐B mice showed lower body weight, mainly due to limited increase in fat mass as compared with control mice. Because LOWOX‐B mice also showed less activity compared with control mice, it is possible that these LOWOX‐B mice shift their metabolism by burning more fat. However, this needs further investigation, for instance by using metabolic cages and body temperature measurements in future studies.

This study has several strengths and limitations. Because the present study includes a mixture of components with antioxidant capacities and does not take individual components in account, it is difficult to distinguish which component was responsible for which outcome. Nevertheless, the elderly population develops deficiencies for multiple micronutrients, associated with sarcopenia, frailty, and disability,[15](#jcsm12237-bib-0015){ref-type="ref"}, [23](#jcsm12237-bib-0023){ref-type="ref"}, [24](#jcsm12237-bib-0024){ref-type="ref"} which makes this design more applicable to the clinical setting. Indeed, our observations on impaired muscle health are clinically relevant for the ageing human population. Selenium deficiency also plays a role in the immune pathway.[52](#jcsm12237-bib-0052){ref-type="ref"} While the effect of the LOWOX‐B diet apparently is not mediated by an inflammatory response, as observed with antioxidant supplementation,[57](#jcsm12237-bib-0057){ref-type="ref"} local immune responses cannot be excluded. In addition, another mechanism we did not touch upon in this study is the neuronal process affected by vitamin E deficiency.[51](#jcsm12237-bib-0051){ref-type="ref"} To study the impact of diets low in antioxidants on neurological factors requires a new designed experiment, including behavioural tests and/or *in situ* muscle force measurements. Finally, mice have limited yield of blood to determine parameters of antioxidant deficiencies. Although serum levels did not reflect the changes in diet concentrations, we cannot make conclusions for selenium, zinc, or vitamin B6, because analyses were practically not feasible. To address this limitation, for instance, we chose to analyse homocysteine, a more indirect measure for defects of vitamin B metabolism.[20](#jcsm12237-bib-0020){ref-type="ref"} In addition, the cages in the study were not equipped to minimize coprophagia, which is not optimal for developing deficiencies. The cages were also galvanized, which for the mice may have resulted in exposure to extra minerals. Also, the drinking water was normal tap water and was not demineralized. Finally, subsequent intervention by nutritional supplementation of micronutrients in future studies could further prove the importance of micronutrients in maintaining muscle function at old age. It is noteworthy that the highest dropout was in the normal aged mice. This could be a coincidence, but one could also speculate that the AIN‐93‐M diet provides some vitamin(s) and mineral(s) in excessive amounts, exceeding the daily recommended requirements of lab animals (*Table* [3](#jcsm12237-tbl-0003){ref-type="table-wrap"}).[29](#jcsm12237-bib-0029){ref-type="ref"} For example, too much vitamin A can lead to birth defects, liver abnormalities, central nervous system disorders, and lower bone mineral density.[60](#jcsm12237-bib-0060){ref-type="ref"} This aspect requires further research.

In conclusion, this study shows that reduced dietary intake of vitamins A, E, B6, and B12, folate, selenium, and zinc has a major impact on muscle health as shown by decreased force‐generating capacity and fatigue resistance as well as impaired physical activity, without an effect on muscle mass. The reduced fCSA in combination with a lack of effect on SDH activity suggests that such dietary reductions cause muscle fibre atrophy and reduced muscle oxidative capacity, which explains the observed changes in muscle contractile properties. The results support the hypothesis that micronutrient deficiencies in elderly contribute to impaired muscle health, leading to accelerated ageing.
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